1
Rapid Test and Treat Dolutegravir Plus Lamivudine Study in Newly Diagnosed Human Immunodeficiency Virus (HIV)-1 Infected Adults
Condition(s):HIV InfectionsLast Updated:October 21, 2021Completed
Lamivudine: 825 Clinical Trials, Page 1 of 83
Hide Studies Not Open or Pending
2
Time to Protection and Adherence Requirements of Raltegravir With or Without Lamivudine in Protection From HIV Infection
Condition(s):HivLast Updated:March 16, 2021Completed
3
Dolutegravir-Lamivudine for naïve HIV-Infected Patients With ≤200 CD4/mm3
Condition(s):HIV-1-infectionLast Updated:September 28, 2021Recruiting
4
Lamivudine/Dolutegravir in Virologically Suppressed Subjects With Expected or Confirmed Resistance to Lamivudine
Condition(s):HIV InfectionsLast Updated:May 11, 2021Not yet recruiting
5
Lopinavir/r/ Lamivudine/ Abacavir as an Easy to Use Paediatric Formulation
Condition(s):HIVLast Updated:June 7, 2019Unknown status
6
Bioequivalence Study Between Lamivudine Formulations in the Form of Coated Tablet of 150 mg in Healthy Volunteers
Condition(s):HIV INFECTIONSLast Updated:November 13, 2015Completed
7
Comparison Between Lamivudine and Entecavir Treatment in Spontaneous Severe Acute Exacerbation
Condition(s):Chronic Hepatitis BLast Updated:October 18, 2016Terminated
8
Pharmacokinetics of Lamivudine at Two Different Doses
Condition(s):HIV InfectionsLast Updated:February 11, 2011Completed
9
Lamivudine Therapy in Patients With Prior Entecavir Treatment and Undetectable Viral Load
Condition(s):Hepatitis B, ChronicLast Updated:December 2, 2015Completed
10
Adefovir and Lamivudine for Entecavir Resistance (ALTER Study)
Condition(s):Chronic Hepatitis BLast Updated:February 17, 2014Completed